We are live on ! Find out more
AVXL icon

Anavex Life Sciences
AVXL

58 hedge funds and large institutions have $53.8M invested in Anavex Life Sciences in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more capital invested

Capital invested by funds: $29.7M → $53.8M (+$24.1M)

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

3.84% more ownership

Funds ownership: 18.95% → 22.79% (+3.8%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 18

2% less funds holding

Funds holding: 59 → 58 (-1)

83% less call options, than puts

Call options by funds: $1.34M | Put options by funds: $7.66M

Holders
58
Holders Change
-1
Holders Change %
-1.69%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
18
Reduced
18
Closed
8
Calls
$1.34M
Puts
$7.66M
Net Calls
-$6.32M
Net Calls Change
-$778K

Top Buyers

1
BlackRock
BlackRock
New York
+$8.28M
2
PWAM
Park West Asset Management
California
+$7.55M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$886K
4
State Street
State Street
Massachusetts
+$686K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$387K

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$454K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$292K
3
TCIM
TIAA CREF Investment Management
New York
-$222K
4
Citigroup
Citigroup
New York
-$155K
5
AIM
Acrospire Investment Management
Illinois
-$115K
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
51
AlphaMark Advisors
Kentucky
$4K – – –
MAM
52
Meeder Asset Management
Ohio
$3K -$4.88K -945 -63%
ASN
53
Advisory Services Network
Georgia
$3K +$2.35K +454 New
BL
54
Balentine LLC
Georgia
$2K – – –
WAS
55
Winch Advisory Services
Wisconsin
$1K -$1.29K -250 -50%
TIM
56
Tortoise Investment Management
New York
$1K – – –
Federated Hermes
57
Federated Hermes
Pennsylvania
$1K +$1.28K +247 New
V
58
Veritable
Delaware
– -$99K -25,000 Closed
DAM
59
Deltec Asset Management
New York
– -$59K -15,000 Closed
VKH
60
Virtu KCG Holdings
New York
– -$48K -12,164 Closed
Goldman Sachs
61
Goldman Sachs
New York
– -$41K -10,384 Closed
Simplex Trading
62
Simplex Trading
Illinois
– -$42.7K -8,271 Closed
TRCT
63
Tower Research Capital (TRC)
New York
– -$20K -5,049 Closed
PNC Financial Services Group
64
PNC Financial Services Group
Pennsylvania
– -$2K -600 Closed
BNP Paribas Financial Markets
65
BNP Paribas Financial Markets
France
– -$887 -224 Closed
1 2
3

AVXL Hedge Fund Activity: Q1 2017 in Review

58 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q1 2017, worth a combined $53.8M — up 81% from $29.7M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new AVXL positions and 8 closed out — a net gain of 3 holders — while 18 added to existing stakes and 18 trimmed.

The largest buyer was BlackRock, adding an estimated $8.28M. The largest seller was Morgan Stanley, cutting an estimated $454K.

  • 58 institutional investors held Anavex Life Sciences (AVXL) as of Q1 2017, down from 59 in Q4 2016.
  • Funds reported $53.8M of Anavex Life Sciences stock for Q1 2017, up 81% quarter-over-quarter.
  • 11 funds opened new Anavex Life Sciences positions in Q1 2017 and 8 closed out, a net change of +3 holders.
  • The largest Anavex Life Sciences buyer in Q1 2017 was BlackRock, an estimated $8.28M added.
  • The largest Anavex Life Sciences seller in Q1 2017 was Morgan Stanley, an estimated $454K sold.

Based on aggregated 13F filings for Q1 2017.